{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19 pneumonitis",
      "Cytokine storm",
      "Inflamatory response",
      "Radiation",
      "SARS-CoV-2"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33502567",
  "DateCompleted": {
    "Year": "2021",
    "Month": "05",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "02",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "01",
        "Day": "27"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s00066-020-01743-4"
    ],
    "Journal": {
      "ISSN": "1439-099X",
      "JournalIssue": {
        "Volume": "197",
        "Issue": "5",
        "PubDate": {
          "Year": "2021",
          "Month": "May"
        }
      },
      "Title": "Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]",
      "ISOAbbreviation": "Strahlenther Onkol"
    },
    "ArticleTitle": "COVID-19 pneumonia treated with ultra-low doses of radiotherapy (ULTRA-COVID study): a\u00a0single institution report of two cases.",
    "Pagination": {
      "StartPage": "429",
      "EndPage": "437",
      "MedlinePgn": "429-437"
    },
    "Abstract": {
      "AbstractText": [
        "Since the outbreak of coronavirus disease 2019 (COVID-19) pandemic, healthcare systems have focused their efforts into finding a\u00a0treatment to avoid the fatal outcomes of severe acute respiratory syndrome due to coronavirus\u20112 (SARS-CoV-2). Benefits and risks of systemic treatments remain unclear, with multiple clinical trials still ongoing. Radiotherapy could play a\u00a0role in reducing the inflammatory response in the lungs and relieve life-threatening symptoms.",
        "We designed a\u00a0prospective study of Ultra-Low Doses of Therapy with Radiation Applied to COVID-19 (ULTRA-COVID) for patients who suffer pneumonia, are not candidates for invasive mechanical ventilation and show no improvement with medical therapy.",
        "We present the preliminary results of two patients diagnosed with COVID-19 pneumonia treated with ULTRA-COVID. After one radiotherapy session, significant clinical response and a\u00a0good radiological response was observed in both cases, resulting in both patients being discharged from hospital in less than 2\u00a0weeks after radiation treatment.",
        "Preliminary clinical and radiological results suggest a\u00a0potential benefit of treating COVID-19 pneumonia with ULTRA-COVID. ClinicalTrials.gov Identifier: NCT04394182."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Radiation Oncology, La Milagrosa Hospital, GenesisCare, Madrid, Spain. escarlata.lopez@genesiscare.es."
          }
        ],
        "LastName": "Moreno-Olmedo",
        "ForeName": "Elena",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Radiation Oncology, La Milagrosa Hospital, GenesisCare, Madrid, Spain."
          }
        ],
        "LastName": "Su\u00e1rez-Gironzini",
        "ForeName": "Vladimir",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine, La Milagrosa Hospital, Madrid, Spain."
          }
        ],
        "LastName": "P\u00e9rez",
        "ForeName": "Manuel",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine, La Milagrosa Hospital, Madrid, Spain."
          }
        ],
        "LastName": "Filigheddu",
        "ForeName": "Teresa",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Radiophysics, La Milagrosa Hospital, GenesisCare, Madrid, Spain."
          }
        ],
        "LastName": "M\u00ednguez",
        "ForeName": "Cristina",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Oral and Maxillofacial Surgeon, Universtiy Hospital Reina Sof\u00eda, C\u00f3rdoba, Spain."
          }
        ],
        "LastName": "Sanjuan-Sanjuan",
        "ForeName": "Alba",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Radiation Oncology, GenesisCare, Seville, Spain."
          }
        ],
        "LastName": "Gonz\u00e1lez",
        "ForeName": "Jos\u00e9 A",
        "Initials": "JA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Radiation Oncology, GenesisCare, M\u00e1laga, Spain."
          }
        ],
        "LastName": "Rivas",
        "ForeName": "Daniel",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Radiodiagnosis, La Milagrosa Hospital, Madrid, Spain."
          }
        ],
        "LastName": "Gorospe",
        "ForeName": "Luis",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Radiation Oncology, Vithas Valencia Consuelo Hospital, Valencia, Spain."
          }
        ],
        "LastName": "Larrea",
        "ForeName": "Luis",
        "Initials": "L"
      },
      {
        "Identifier": [
          "0000-0001-5239-3852"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Radiation Oncology, La Milagrosa Hospital, GenesisCare, Madrid, Spain."
          }
        ],
        "LastName": "L\u00f3pez",
        "ForeName": "Escarlata",
        "Initials": "E"
      }
    ],
    "DataBankList": [
      {
        "DataBankName": "ClinicalTrials.gov",
        "AccessionNumberList": [
          "NCT04394182"
        ]
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Clinical Trial",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Strahlenther Onkol",
    "NlmUniqueID": "8603469",
    "ISSNLinking": "0179-7158"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "pathology",
        "radiotherapy"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Preliminary Data"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prospective Studies"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Radiotherapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Radiotherapy Dosage"
    },
    {
      "QualifierName": [
        "radiation effects"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ],
  "CoiStatement": "E.\u00a0Moreno-Olmedo, V.\u00a0Su\u00e1rez-Gironzini, M.\u00a0P\u00e9rez, T.\u00a0Filigheddu., C.\u00a0M\u00ednguez, A.\u00a0Sanjuan-Sanjuan, J.A.\u00a0Gonz\u00e1lez, D.\u00a0Rivas, L.\u00a0Gorospe, L.\u00a0Larrea and E.\u00a0L\u00f3pez declare that they have no competing interests."
}